GB2579036A - Compositions comprising amino acids - Google Patents
Compositions comprising amino acids Download PDFInfo
- Publication number
- GB2579036A GB2579036A GB1818629.6A GB201818629A GB2579036A GB 2579036 A GB2579036 A GB 2579036A GB 201818629 A GB201818629 A GB 201818629A GB 2579036 A GB2579036 A GB 2579036A
- Authority
- GB
- United Kingdom
- Prior art keywords
- total solid
- amino acids
- mixture
- solid weight
- isolated amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 235
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 168
- 235000001014 amino acid Nutrition 0.000 claims abstract description 167
- 239000007787 solid Substances 0.000 claims abstract description 148
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 88
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims abstract description 47
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims abstract description 47
- 229960002591 hydroxyproline Drugs 0.000 claims abstract description 47
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims abstract description 47
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims abstract description 46
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims abstract description 45
- 235000004279 alanine Nutrition 0.000 claims abstract description 45
- 239000004475 Arginine Substances 0.000 claims abstract description 44
- 239000004471 Glycine Substances 0.000 claims abstract description 44
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 44
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims abstract description 43
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims abstract description 42
- 239000002775 capsule Substances 0.000 claims abstract description 16
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 42
- 239000007788 liquid Substances 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 6
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 6
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 6
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 6
- 235000020806 vegan diet Nutrition 0.000 description 24
- 102000008186 Collagen Human genes 0.000 description 23
- 108010035532 Collagen Proteins 0.000 description 23
- 229920001436 collagen Polymers 0.000 description 23
- 241000196324 Embryophyta Species 0.000 description 16
- 235000003563 vegetarian diet Nutrition 0.000 description 9
- 239000002537 cosmetic Substances 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 7
- 239000000654 additive Substances 0.000 description 6
- -1 for example Proteins 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000036620 skin dryness Effects 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 244000298479 Cichorium intybus Species 0.000 description 2
- 235000007542 Cichorium intybus Nutrition 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 235000003650 acai Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 244000064816 Brassica oleracea var. acephala Species 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 240000006162 Chenopodium quinoa Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000723298 Dicentrarchus labrax Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
- 244000043158 Lens esculenta Species 0.000 description 1
- 241000408747 Lepomis gibbosus Species 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 108010084695 Pea Proteins Proteins 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000020235 chia seed Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- VEVRNHHLCPGNDU-MUGJNUQGSA-O desmosine Chemical compound OC(=O)[C@@H](N)CCCC[N+]1=CC(CC[C@H](N)C(O)=O)=C(CCC[C@H](N)C(O)=O)C(CC[C@H](N)C(O)=O)=C1 VEVRNHHLCPGNDU-MUGJNUQGSA-O 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- RGXCTRIQQODGIZ-UHFFFAOYSA-O isodesmosine Chemical compound OC(=O)C(N)CCCC[N+]1=CC(CCC(N)C(O)=O)=CC(CCC(N)C(O)=O)=C1CCCC(N)C(O)=O RGXCTRIQQODGIZ-UHFFFAOYSA-O 0.000 description 1
- 235000021332 kidney beans Nutrition 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000019702 pea protein Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000020236 pumpkin seed Nutrition 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/445—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Abstract
A composition comprising a mixture of isolated amino acids, the mixture of isolated amino acids comprising: a) 15 to 35 wt% glycine, based on the total solid weight of a) to g), b) 5 to 25 wt% proline, based on the total solid weight of a) to g), c) 5 to 25 wt% glutamine, based on the total solid weight of a) to g), d) 5 to 25 wt% hydroxyproline, based on the total solid weight of a) to g), e) 1 to 20 wt% arginine, based on the total solid weight of a) to g), f) 1 to 20 wt% alanine, based on the total solid weight of a) to g) and g) 1 to 15 wt% D-aspartic acid, based on the total solid weight of a) tog); wherein the amount of a), b), c), d), e), f) and g) gives a total of 100 wt% based on the total solid weight of a) to g). The composition may be included in a capsule or tablet and may be used to improve the appearance of the skin.
Description
Compositions Comprising Amino Acids
FIELD
[1] The present invention relates to compositions comprising amino acids, in particular to compositions comprising a mixture of isolated amino acids.
BACKGROUND
[2] Collagen is a polypeptide that is known have beneficial effects on the skin. For example, collagen can be applied to the skin of a human subject and/or ingested by a human subject in order to improve the appearance of the skin, for example, by reducing the appearance of wrinkles and/or by reducing skin dryness. It is therefore thought that taking and/or applying collagen may reduce, for example, skin aging.
[3] The collagen used in known products is typically marine collagen. Collagen used in known products may also be from bovine, porcine or poultry, such as chicken, sources. Marine collagen is collagen that is extracted, and optionally purified, from marine sources such as, for example, filapia, sea bass, and tuna. Once applied and/or taken by a human subject, the marine collagen is broken down and the amino acid constituents may then be used by the body to stimulate fibroblasts which in turn stimulate the formation of collagen. In this manner, more collagen is produced by the human subject and said improvements, such as reducing fine lines and/or skin dryness, may be observed. However, marine collagen is not suitable for those on a vegetarian and/or a vegan diet. Furthermore, stocks of marine collagen are in decline. It is known that collagen may be extracted from egg shells, however, there are presently no known sources of collagen that are suitable for those following a vegan diet.
[4] There is therefore a desire to move away from marine collagen as a source of collagen. Further, there is a desire to provide a source of collagen that is suitable for those following a vegan diet.
[5] It is an object of aspects of the present invention to provide one or more solutions to one of the above mentioned or other problems.
SUMMARY
[6] According to a first aspect of the present invention there is provided a composition comprising a mixture of isolated amino acids, the mixture of isolated amino acids comprising: a) 15 to 35 wt% glycine, based on the total solid weight of a) to g); b) 5 to 25 wt% proline, based on the total solid weight of a) to g); c) 5 to 25 wt% glutamine, based on the total solid weight of a) to g); d) 5 to 25 wt% hydroxyproline, based on the total solid weight of a) to g); e) 1 to 20 wt% arginine, based on the total solid weight of a) to g); 9 1 to 20 wt% alanine, based on the total solid weight of a) to g); and g) 1 to 15 wt% D-aspartic acid, based on the total solid weight of a) to g); wherein the amount of a), b), c), d), e), f) and g) gives a total of 100 wt% based on the total solid weight of a) to g).
[07] Suitably, components a) to g) may each be from a plant-based source.
[08] Therefore, according to a second aspect of the present invention there is provided a composition comprising a mixture of isolated amino acids, the mixture of isolated amino acids comprising: a) 15 to 35 wt% glycine, based on the total solid weight of a) to g); b) 5 to 25 wt% proline, based on the total solid weight of a) to g); c) 5 to 25 wt% glutamine, based on the total solid weight of a) to g); d) 5 to 25 wt% hydroxyproline, based on the total solid weight of a) to g); e) 1 to 20 wt% arginine, based on the total solid weight of a) to g); 0 1 to 20 wt% alanine, based on the total solid weight of a) to g); and g) 1 to 15 wt% D-aspartic acid, based on the total solid weight of a) to g); wherein the amount of a), b), c), d), e), 0 and g) gives a total of 100 wt% based on the total solid weight of a) to g); and wherein components a) to g) are each form a plant-based source.
[09] Advantageously, the use of amino acids from a plant-based source in the mixture of isolated amino acids means that the composition is suitable for use by those following a vegetarian and/or vegan diet. It will be appreciated by a person skilled in the art that a vegan diet is a diet that derives from plant-based sources and is not derived from animal-based sources. It will also be appreciated by a person skilled in the art that a vegetarian diet is a diet that does not include meat but that can include other animal-based sources of food such as, for example, diary products, including, for example, milk, cheese and eggs. For the avoidance of doubt, the term "vegan diet" encompasses those following a vegan diet and/or a vegan lifestyle (where a subject does not include any animal-based sources in their lifestyle be it foodstuffs, cosmetics, or otherwise).
[10] Advantageously, it has been found by the present inventors that the mixture of isolated amino acids of the present invention has a similar effect to that of, for example, marine collagen, in a human or non-human animal subject. For example, it has advantageously been found by the present inventors that the amino acid profile of the mixture of isolated amino acids is substantially equivalent to the amino acid profile of marine collagen in that the most prevalent amino acids from the breakdown of the marine collagen are also the most prevalent amino acids in the mixture of isolated amino acids.
DESCRIPTION
[11] The composition of the present invention comprises a mixture of isolated amino acids. By the term "isolated", and like terms as used herein, when used in reference to the amino acids is meant that each of the amino acids a) to g) are present in the isolated amino acid mixture as individual molecules (or compounds) and are not, for example, present as a residue (or monomer) in a protein, such as, for example, collagen, a polypeptide and/or an oligomer. Thus, the amino acids a) to g) of the mixture of isolated amino acids of the present invention are not bonded together.
[12] The mixture of isolated amino acids comprises 15 to 35 wt% glycine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 to 35 wt% glycine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 16, 17, 18, 19, 20, 21, 22, 23, 24,25 or 26 to 34 wt% glycine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 to 33 wt% glycine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 16. 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 to 32 wt% glycine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 to 31 wt% glycine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 to 30 wt% glycine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 to 29 wt% glycine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 16, 17, 18, 19, 20, 21, 22, 23, 24,25 or 26 to 28 wt% glycine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 to 27 wt% glycine based on the total solid weight of components a) to g).
[13] Suitably, the mixture of isolated amino acids may comprise from 20 to 30 wt%, more suitably from 22 to 28 wt%, even more suitably from 25 to 27 wt% glycine based on the total solid weight of components a) to g).
[14] Suitably, the mixture of isolated amino acids may comprise from 26 to 27 wt% glycine based on the total solid weight of components a) to g).
[15] The mixture of isolated amino acids comprises 5 to 25 wt% proline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16 to 25 wt% praline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16 to 24 wt% proline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16 to 23 wt% proline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16 to 22 wt% proline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16 to 21 wt% proline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16 to 20 wt% proline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16 to 19 wt% proline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16 to 18 wt% proline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8,9, 10, 11, 12, 13, 14, 15 or 16 to 17 wt% proline based on the total solid weight of components a) to g).
[16] Suitably, the mixture of isolated amino acids may comprise from 10 to 20 wt%, more suitably from 12 to 18 wt%, even more suitably 15 to 17 wt% proline based on the total solid weight of components a) to g).
[17] Suitably, the mixture of isolated amino acids may comprise from 16 to 17 wt% proline based on the total solid weight of components a) to g).
[18] The mixture of isolated amino acids comprises 5 to 25 wt% glutamine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12, 13 or 14 to 25 wt% glutamine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12, 13 or 14 to 24 wt% glutamine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12, 13 or 14 to 23 wt% glutamine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12, 13 or 14 to 22 wt% glutamine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12, 13 or 14 to 21 wt% glutamine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12, 13 or 14 to 20 wt% glutamine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8,9, 10, 11, 12, 13 or 14 to 19 wt% glutamine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12, 13 or 14 to 18 wt% glutamine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12, 13 or 14 to 17 wt% glutamine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12, 13 01 14 to 16 wt% glutamine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12, 13 or 14 to 15 wt% glutamine based on the total solid weight of components a) to g).
[19] Suitably, the mixture of isolated amino acids may comprise from 10 to 20 wt%, more suitably from 12 to 18 wt%, even more suitably 13 to 16 wt% glutamine based on the total solid weight of components a) to g).
[20] Suitably, the mixture of isolated amino acids may comprise from 14 to 15 wt% glutamine based on the total solid weight of components a) to g).
[21] The mixture of isolated amino acids comprises 5 to 25 wt% hydroxyproline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12 or 13 to 25 wt% hydroxyproline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12 or 13 to 24 wt% hydroxyproline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12 or 13 to 23 wt% hydroxyproline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6,7, 8, 9, 10, 11, 12 or 13 to 22 wt% hydroxyproline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12 or 13 to 21 wt% hydroxyproline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12 or 13 to 20 wt% hydroxyproline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12 or 13 to 19 wt% hydroxyproline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12 or 13 to 18 wt% hydroxyproline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12 or 13 to 17 wt% hydroxyproline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12 or 13 to 16 wt% hydroxyproline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6, 7, 8, 9, 10, 11, 12 or 13 to 15 wt% hydroxyproline based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 6,7, 8, 9, 10, 11, 12 or 13 to 14 wt% hydroxyproline based on the total solid weight of components a) to g).
[22] Suitably, the mixture of isolated amino acids may comprise from 10 to 20 wt%, more suitably from 11 to 18 wt%, even more suitably 12 to 15 wt% hydroxyproline based on the total solid weight of components a) to g).
[23] Suitably, the mixture of isolated amino acids may comprise from 13 to 14 wt% hydroxyproline based on the total solid weight of components a) to g).
[24] The mixture of isolated amino acids comprises 1 to 20 wt% arginine based on the total solid weight of a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5, 6, 7, 8, 9,10 or 11 to 20 wt% arginine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11 to 19 wt% arginine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11 to 18 wt% arginine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11 to 17 wt% arginine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11 to 16 wt% arginine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3,4, 5,6, 7, 8, 9, 10 or 11 to 15 wt% arginine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11 to 14 wt% arginine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11 to 13 wt% arginine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11 to 12 wt% arginine based on the total solid weight of components a) to g).
[25] Suitably, the mixture of isolated amino acids may comprise from 5 to 15 wt%, more suitably from 8 to 13 wt%, even more suitably from 10 to 12 wt% arginine based on the total solid weight of components a) to g).
[26] Suitably, the mixture of isolated amino acids may comprise from 11 to 12 wt% arginine based on the total solid weight of components a) to g).
[27] The mixture of isolated amino acids comprises 1 to 20 wt% alanine based on the total solid weight of a) to g). The mixture of isolated amino acids may comprise from 2, 3,4, 5, 6, 7, 8, 9 or 10 to 20 wt% alanine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5,6, 7, 8, 9 or 10 to 19 wt% alanine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5, 6, 7, 8, 9 or 10 to 18 wt% alanine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5, 6, 7, 8, 9 or 10 to 17 wt% alanine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3,4, 5,6, 7, 8, 9 or 10 to 16 wt% alanine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5, 6, 7, 8, 9 or 10 to 15 wt% alanine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2,3, 4, 5,6, 7,8, 9 or 10 to 14 wt% alanine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5,6, 7,8, 9 or 10 to 13 wt% alanine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5, 6, 7, 8, 9 or 10 to 12 wt% alanine based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5, 6, 7, 8, 9 or 10 to 11 wt% alanine based on the total solid weight of components a) to g).
[28] Suitably, the mixture of isolated amino acids may comprise from 5 to 15 wt%, more suitably from 7 to 12 wt%, even more suitably from 9 to 11 wt% alanine based on the total solid weight of components a) to g).
[29] Suitably, the mixture of isolated amino acids may comprise from 10 to 11 wt% alanine based on the total solid weight of components a) to g).
[30] The mixture of isolated amino acids comprises Ito 15 wt% D-aspartic acid based on the total solid weight of a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5 or 6 to 15 wt% D-aspartic acid based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5 or 6 to 14 wt% D-aspartic acid based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5 or 6 to 13 wt% D-aspartic acid based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5 or 6 to 12 wt% D-aspartic acid based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5 or 6 to 11 wt% D-aspartic acid based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5 or 6 to 10 wt% D-aspartic acid based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5 or 6 to 9 wt% D-aspadic acid based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5 or 6 to 8 wt% D-aspartic acid based on the total solid weight of components a) to g). The mixture of isolated amino acids may comprise from 2, 3, 4, 5 or 6 to 7 wt% D-aspartic acid based on the total solid weight of components a) to g).
[31] Suitably, the mixture of isolated amino acids may comprise from 1 to 10 wt%, more suitably from 2 to 8 wt%, even more suitably from 5 to 7 wt% D-aspartic acid based on the total solid weight of components a) to g).
[32] Suitably, the mixture of isolated amino acids may comprise from 6 to 7 wt% D-aspartic acid based on the total solid weight of components a) to g).
[33] For the avoidance of doubt, by the term "the amount of a), b), c), d), e), f) and g) gives a total of 100 wt%" is meant that the relative amount of each of components a) to g) totals 100 wt% in the mixture of isolated amino acids and does not mean that the components a) to g) total 100 wt% of the overall composition (and is such that further components may be present in the overall composition).
[34] The mixture of isolated amino acids may comprise any suitable weight ratio of a) glycine to b) proline. Suitably, the weight ratio of a) glycine to b) proline may be at least 1:1, such as at least 1.1:1, such as at least 1.2:1, such as at least 1.3:1, such as at least 1.4:1, or even at least 1.5:1. Suitably, the weight ratio of a) glycine to b) proline may be up to 2:1, such as up to 1.9:1, such as up to 1.8:1, such as up to 1.7:1. Suitably, the weight ratio of a) glycine to b) proline may be 1.6:1.
[35] The mixture of isolated amino acids may comprise any suitable weight ratio of a) glycine to c) glutamine. Suitably, the weight ratio of a) glycine to c) glutamine may be at least 1:1, such as at least 1.2:1, such as at least 1.3:1, such as at least 1.4:1, such as at least 1.5:1, or even at least 1.6:1. Suitably, the weight ratio of a) glycine to c) glutamine may be up to 2.5:1, such as up to 2.4:1, such as up to 2.3:1, such as up to 2.2:1, such as up to 2.1:1, such as up to 2:1, such as up to 1.9:1. Suitably, the weight ratio of a) glycine to c) glutamine may be 1.8:1.
[36] The mixture of isolated amino acids may comprise any suitable weight ratio of a) glycine to d) hydroxyproline. Suitably, the weight ratio of a) glycine to d) hydroxyproline may be at least 1:1, such as at least 1.1:1, such as at least 1.2:1, such as at least 1.3:1, such as at least 1.4:1, such as at least 1.5:1, such as at least 1.6:1, such as at least 1.7:1, or even at least 1.8:1. Suitably, the weight ratio of a) glycine to d) hydroxyproline may be up to 2.6:1, such as be up to 2.5:1, such as up to 2.4:1, such as up to 2.3:1, such as up to 2.2:1, such as up to 2.1:1. Suitably, the weight ratio of a) glycine to d) hydroxyproline may be 2:1.
[37] The mixture of isolated amino acids may comprise any suitable weight ratio of a) glycine to e) arginine. Suitably, the weight ratio of a) glycine to e) arginine may be at least 1.5:1, such as at least 1.6:1, such as at least 1.7:1, such as at least 1.8:1, such as at least 1.9:1, such as at least 2:1, such as at least 2.1:1, or even at least 2.2:1. Suitably, the weight ratio of a) glycine to e) arginine may be up to 3.1:1, such as up to 3:1, such as up to 2.9:1, such as up to 2.8:1, such as up to 2.7:1, such as up to 2.6:1, such as up to 2.5:1, such as up to 2.4:1. Suitably, the weight ratio of a) glycine to e) arginine may be 2.3:1.
[38] The mixture of isolated amino acids may comprise any suitable weight ratio of a) glycine to 0 alanine. Suitably, the weight ratio of a) glycine to 0 alanine may be at least 1.5:1, such as at least 1.6:1, such as at least 1.7:1, such as at least 1.8:1, such as at least 1.9:1, such as at least 2:1, such as at least 2.1:1, such as at least 2.2:1, such as at least 2.3:1, such as at least 2.4:1, or even at least 2.5:1. Suitably, the weight ratio of a) glycine to D alanine may be up to 3.3:1, such as up to 3.2:1, such as up to 3.1:1, such as up to 3:1, such as up to 2.9:1, such as up to 2.8:1, such as up to 2.7:1, such as up to 2.6:1. Suitably, the weight ratio of a) glycine to t) alanine may be 2.5:1.
[39] The mixture of isolated amino acids may comprise any suitable weight ratio of a) glycine to g) D-aspartic acid. Suitably, the weight ratio of a) glycine to g) D-aspartic acid may be at least 1.8:1, such as at least 1.9:1, such as at least 2:1, such as at least 2.1:1, such as at least 2.2:1, such as at least 2.3:1, such as at least 2.4:1, such as at least 2.5:1, such as at least 2.6:1, such as at least 2.7:1, such as at least 2.8:1, such as at least 2.9:1, such as at least 3:1, such as at least 3.1:1, such as at least 3.2:1, such as at least 3.3:1, such as at least 3.4:1, or even at least 3.5:1. Suitably, the weight ratio of a) glycine to g) D-aspartic acid may be up to 5.3:1, such as up to 5.2:1, such as up to 5.1:1, such as up to 5:1, such as up to 4.9:1, such as up to 4.8:1, such as up to 4.7:1, such as up to 4.6:1, such as up to 4.5:1, such as up to 4.4:1, such as up to 4.3:1, such as up to 4.2:1. Suitably, the weight ratio of a) glycine to g) D-aspartic acid may be 4.1.
[40] The mixture of isolated amino acids may comprise any suitable weight ratio of b) proline to c) glutamine. Suitably, the weight ratio of b) proline to c) glutamine may be at least 1:1. Suitably, the weight ratio of b) proline to c) glutamine may be up to 1.7:1, such as up to 1.6:1, such as up to 1.5:1, such as up to 1.4:1, such as up to 1.3:1, such as up to 1.2:1. Suitably, the weight ratio of b) proline to c) glutamine may be 1.1:1.
[41] The mixture of isolated amino acids may comprise any suitable weight ratio of b) proline to d) hydroxyproline. Suitably, the weight ratio of b) proline to d) hydroxyproline may be at least 1:1, or even at least 1.1:1. Suitably, the weight ratio of b) proline to d) hydroxyproline may be up to 1.9:1, such as up to 1.8:1, such as up to 1.7:1, such as up to 1.6:1, such as up to 1.5:1, such as up to 1.4:1, such as up to 1.3:1. Suitably, the weight ratio of b) proline to d) hydroxyproline may be 1.2:1.
[42] The mixture of isolated amino acids may comprise any suitable weight ratio of b) proline to e) arginine. Suitably, the weight ratio of b) proline to e) arginine may be at least 1:1, such as at least 1.1:1, such as at least 1.2:1, such as at least 1.3:1, or even at least 1.4:1. Suitably, the weight ratio of b) proline to e) arginine may be up to 2.2:1, such as up to 2.1:1, such as up to 2:1, such as up to 1.9:1, such as up to 1.8:1, such as up to 1.7:1, such as up to 1.6:1. Suitably, the weight ratio of b) proline to e) arginine may be 1.5:1.
[43] The mixture of isolated amino acids may comprise any suitable weight ratio of b) proline to l alanine. Suitably, the weight ratio of b) proline to f) alanine may be at least 1:1, such as at least 1.1:1, such as at least 1.2:1, such as at least 1.3:1, such as at least 1.4:1, or even at least 1.5:1. Suitably, the weight ratio of b) proline to f) alanine may be 2.3:1, such as up to 2.2:1, such as up to 2.1:1, such as up to 1.9:1, such as up to 1.8:1, such as up to 1.7:1. Suitably, the weight ratio of b) proline to t) alanine may be 1.6:1.
[44] The mixture of isolated amino acids may comprise any suitable weight ratio of b) proline to g) D-aspartic acid. Suitably, the weight ratio of b) proline to g) D-aspartic acid may be at least 1.1:1, such as at least 1.2:1, such as at least 1.3:1, such as at least 1.4:1, such as at least 1.5:1, such as at least 1.6:1, such as at least 1.7:1, such as at least 1.8:1, such as at least 1.9:1, such as at least 2:1, such as at least 2.1:1, such as at least 2.2:1, such as at least 2.3:1, or even at least 2.4:1. Suitably, the weight ratio of b) proline to g) D-aspartic acid may be up to 3.8:1, such as up to 3.7:1, such as up to 3.6:1, such as up to 3.5:1, such as up to 3.4:1, such as up to 3.3:1, such as up to 3.2:1, such as up to 3.1:1, such as up to 3:1, such as up to 2.9:1, such as up to 2.8:1, such as up to 2.7:1, such as up to 2.6:1. Suitably, the weight ratio of b) proline to g) Daspartic acid may be 2.5:1.
[45] The mixture of isolated amino acids may comprise any suitable weight ratio of c) glutamine to d) hydroxyproline. Suitably, the weight ratio of c) glutamine to d) hydroxyproline may be at least 1:1. Suitably, the weight ratio of c) glutamine to d) hydroxyproline may be up to 1.9:1, such as up to 1.8:1, such as up to 1.7:1, such as up to 1.6:1, such as up to 1.5:1, such as up to 1.4:1, such as up to 1.3:1, such as up to 1.2:1. Suitably, the weight ratio of c) glutamine to d) hydroxyproline may be 1.1:1.
[46] The mixture of isolated amino acids may comprise any suitable weight ratio of c) glutamine to e) arginine. Suitably, the weight ratio of c) glutamine to e) arginine may be at least 1:1, such as at least 1.1:1, or even at least 1.2:2. Suitably, the weight ratio of c) glutamine to e) arginine may be up to 2.2:1, such as up to 2.1:1, such as up to 1.9:1, such as up to 1.8:1, such as up to 1.7:1, such as up to 1.6:1, such as up to 1.5:1, such as up to 1.4:1. Suitably, the weight ratio of c) glutamine to e) arginine may be 1.3:1.
[47] The mixture of isolated amino acids may comprise any suitable weight ratio of c) glutamine to f) alanine. Suitably, the weight ratio of c) glutamine to f) alanine may be at least 1:1, such as at least 1.1:1, or even at least 1.2:2. Suitably, the weight ratio of c) glutamine to t) alanine may be up to 2.3:1, such as up to 2.2:1, such as up to 2.1:1, such as up to 1.9:1, such as up to 1.8:1, such as up to 1.7:1, such as up to 1.6:1, such as up to 1.5:1. Suitably, the weight ratio of c) glutamine tot) alanine may be 1.4:1.
[48] The mixture of isolated amino acids may comprise any suitable weight ratio of c) glutamine to g) D-aspartic acid. Suitably, the weight ratio of c) glutamine to g) D-aspartic acid may be at least 1:1, such as at least 1.1:1, or even at least 1.2:2, such as at least 1.3:1, such as at least 1.4:1, such as at least 1.5:1, such as at least 1.6:1, such as at least 1.7:1, such as at least 1.8:1, such as at least 1.9:1, such as at least 2:1, such as at least 2.1:1, or even at least 2.2:1. Suitably, the weight ratio of c) glutamine to g) D-aspartic acid may be up to 3.8:1, such as up to 3.7:1, such as up to 3.6:1, such as up to 3.5:1, such as up to 3.4:1, such as up to 3.3:1, such as up to 3.2:1, such as up to 3.1:1, such as up to 3:1, such as up to 2.9:1, such as up to 2.8:1, such as up to 2.7:1, such as up to 2.6:1, such as up to 2.5:1, such as up to 2.4:1. Suitably, the weight ratio of c) glutamine to g) D-aspartic acid may be 2.3:1.
[49] The mixture of isolated amino acids may comprise any suitable weight ratio of d) hydroxyproline to e) arginine. Suitably, the weight ratio of d) hydroxyproline to e) arginine may be at least 1:1, or even at least 1.1:1. Suitably, the weight ratio of d) hydroxyproline to e) arginine may be up to 2.2:1, such as up to 2.1:1, such as up to 1.9:1, such as up to 1.8:1, such as up to 1.7:1, such as up to 1.6:1, such as up to 1.5:1, such as up to 1.4:1, such as up to 1.3:1. Suitably, the weight ratio of d) hydroxyproline to e) arginine may be 1.2:1.
[50] The mixture of isolated amino acids may comprise any suitable weight ratio of d) hydroxyproline tot) alanine. Suitably, the weight ratio of d) hydroxyproline tot) alanine may be at least 1:1, such as at least 1.1:1, or even at least 1.2:1. Suitably, the weight ratio of d) hydroxyproline to f) alanine may be up to 2.3:1, such as up to 2.2:1, such as up to 2.1:1, such as up to 1.9:1, such as up to 1.8:1, such as up to 1.7:1, such as up to 1.6:1, such as up to 1.5:1, such as up to 1.4:1. Suitably, the weight ratio of d) hydroxyproline to f) alanine may be 1.3:1.
[51] The mixture of isolated amino acids may comprise any suitable weight ratio of d) hydroxyproline to g) D-aspartic acid. Suitably, the weight ratio of d) hydroxyproline to g) D-aspartic acid may be at least 1:1, such as at least 1.1:1, such as at least 1.2:1, such as at least 1.3:1, such as at least 1.4:1, such as at least 1.5:1, such as at least 1.6:1, such as at least 1.7:1, such as at least 1.8:1, such as at least 1.9:1, or even at least 2:1. Suitably, the weight ratio of d) hydroxyproline to g) D-aspartic acid may be up to 3.8:1, such as up to 3.7:1, such as up to 3.6:1, such as up to 3.5:1, such as up to 3.4:1, such as up to 3.3:1, such as up to 3.2:1, such as up to 3.1:1, such as up to 3:1, such as up to 2.9:1, such as up to 2.8:1, such as up to 2.7:1, such as up to 2.6:1, such as up to 2.5:1, such as up to 2.4:1, such as up to 2.3:1, such as up to 2.2:1. Suitably, the weight ratio of d) hydroxyproline to g) D-aspartic acid may be 2.1:1.
[52] The mixture of isolated amino acids may comprise any suitable weight ratio of e) arginine to 0 alanine. Suitably, the weight ratio of e) arginine to f) alanine may be at least 1:1. Suitably, the weight ratio of e) arginine to f) alanine may be up to 1.9:1, such as up to 1.8:1, such as up to 1.7:1, such as up to 1.6:1, such as up to 1.5:1, such as up to 1.4:1, such as up to 1.3:1, such as up to 1.2:1. Suitably, the weight ratio of e) arginine to f) alanine may be 1.1:1.
[53] The mixture of isolated amino acids may comprise any suitable weight ratio of e) arginine to g) D-aspartic acid. Suitably, the weight ratio of e) arginine to g) D-aspartic acid may be at least 1:1, such as at least 1.1:1, such as at least 1.2:1, such as at least 1.3:1, such as at least 1.4:1, such as at least 1.5:1, or even at least 1.6:1. Suitably, the weight ratio of e) arginine to g) D-aspartic acid may be up to 3.1:1, such as up to 3:1, such as up to 2.9:1, such as up to 2.8:1, such as up to 2.7:1, such as up to 2.6:1, such as up to 2.5:1, such as up to 2.4:1, such as up to 2.3:1, such as up to 2.2:1, such as up to 2.1:1, such as up to 2:1, such as up to 1.9:1, such as up to 1.8:1. Suitably, the weight ratio of e) arginine to g) D-aspartic acid may be 1.7:1.
[54] The mixture of isolated amino acids may comprise any suitable weight ratio of f) alanine to g) D-aspartic acid. Suitably, the weight ratio of f) alanine to g) D-aspartic acid may be at least 1:1, such as at least 1.1:1, such as at least 1.2:1, such as at least 1.3:1, such as at least 1.4:1, or even at least 1.5:1. Suitably, the weight ratio of f) alanine to g) D-aspartic acid may be up to 3.1:1, such as up to 3:1, such as up to 2.9:1, such as up to 2.8:1, such as up to 2.7:1, such as up to 2.6:1, such as up to 2.5:1, such as up to 2.4:1, such as up to 2.3:1, such as up to 2.2:1, such as up to 2.1:1, such as up to 2:1, such as up to 1.9:1, such as up to 1.8:1, such as up to 1.7:1. Suitably, the weight ratio of t) alanine to g) D-aspartic acid may be 1.6:1.
[55] Suitably, components a) to g) of the mixture of isolated amino acids may each be from a plant-based source. Components a) to g) of the mixture of isolated amino acids may be from any suitable plant-based source. Suitable plant-based sources include, but are not limited to, one or more of the following: plant roots, such as chicory; acai berries; seaweed; pea protein; beans, such as soybeans, kidney beans and black beans; seeds, such as chia seeds, sesame seeds, sunflower seeds, almonds, hemp seeds and pumpkin seeds; lentils; chicory; whole grains; legumes; collard greens such as cabbage, broccoli and kale; goji berries; quinoa; spinach; tofu; and combinations thereof The plant-based source may comprise a fermented product. For example, the plant-based product may comprise the fermentation product of any one or more of the suitable plant-based sources described herein Each amino acid a) to g) may be from the same plant-based source or may be from a different plant-based source.
[56] Components a) to g) may each be commercially available. Suitable commercial sources will be well known to a person skilled in the art. Suitably, components a) to g) may be commercially available in the form of a powder.
[57] The composition may comprise any suitable amount of the mixture of isolated amino acids. For example, the composition may comprise at least 50 wt%, such as at least 55 wt%, such as at least 60 wt%, such as at least 65 wt%, such as at least 70 wt%, such as at least 75 wt%, such as at least 80 wt%, such as at least 85 wt%, such as at least 90 wt%, such as at least 95 wt%, or even at least 99 wt% of the mixture of isolated amino acids based on the total solid weight of the composition. The composition may comprise up to 50 wt%, such as up to 45 wt%, such as up to 40 wt%, such as up to 35 wt%, such as 30 wt%, such as 25 wt%, such as 20 wt%, such as 15 wt%, such as 10 wt%, such as 5 wt%, or even up to 1 wt% of further ingredients.
[58] In certain embodiments, the composition may comprise 100 wt% of the mixture of isolated amino acids based on the total solid weight of the composition. It will be appreciated by a person skilled in the art that in such embodiments, i.e. when the composition comprises 100 wt% of the mixture of isolated amino acids based on the total solid weight of the composition, the composition consists essentially of components a) to g) of the mixture of isolated amino acids.
[59] In certain alternative embodiments, the composition may comprise further ingredients. For example, the composition may comprise: further amino acids, such as L-cysteine, desmosine and isodesmosine; hyaluronic acid; glucosamine; proteins, such as glycoproteins; chrondoitin sulphate; vitamins, such as vitamin A, vitamin C, vitamin E, riboflavin (vitamin B2), niacin (vitamin B3), pantothenic acid (vitamin B5) and pryidoxide (vitamin B6); zinc; copper; fatty acids, such as omega 3, 6 and 9 fatty acids; acai berry; and mixtures thereof.
[60] Suitably, the further ingredients, when present, may be from plant-based sources. Suitable plant-based sources are as described above in relation to suitable plant-based sources of components a) to g) of the mixture of isolated amino acids. It will be appreciated by a person skilled in the art that any further components present should suitably be suitable for those following a vegetarian and/or vegan diet, more suitably for those following a vegan diet.
[61] The mixture of isolated amino acids may be in any suitable from. For example, the mixture of isolated amino acids may be in the form of a liquid, a powder and/or a dispersion. Suitably, the mixture of isolated amino acids may be a powder.
[62] The composition may be in any suitable form. Suitably, the composition may be a powder.
[63] Suitably, the composition of the present invention may be applied to, ingested by and/or injected into a subject, such as a human or a non-human animal. More suitably, the composition of the present invention may be applied to, ingested by and/or injected into human a subject. For example, the composition may be ingested in the form of a tablet and/or capsule, may be ingested in the form of a drink and/or foodstuff, suitably to drinks and/or foodstuffs suitable for those following a vegetarian and/or vegan diet, more suitably for those following a vegan diet, and/or may be applied to the skin in the form of a cosmetic composition such as a cream and/or a wound dressing.
[64] Thus, in certain embodiments, the composition may be in the form of a tablet. Methods of forming the composition into a tablet will be known to a person skilled in the art. Suitably, the composition may be formed into a tablet in the powder form. Suitably, when the composition is in the form of a tablet, the composition may be a compressed powder. Suitably, when the composition is in the form of a tablet, the tablet may be coated or uncoated.
[65] In certain embodiments, the composition may further comprise a capsule. The capsule may be formed from any suitable material. Suitably, the capsule is made from a material that is suitable for those following a vegan diet. Suitably, therefore, the capsule may be formed from a material from a plant-source Suitably, the capsule is formed from a gel, more suitably from a gel from a plant-source. More suitably, the capsule is formed from hydroxypropyl methylcellulose (HPMC). Suitably, the composition may be comprised within a capsule. More suitably, the compositions may be comprised within a capsuled formed from hydroxypropyl methylcellulose (HPMC).
[66] In certain embodiments, the composition may be added to a liquid. Suitable liquids will be well known to a person skilled in the art. Suitable liquids include, but are not limited to, water, soft drinks, tea, coffee, fruit juice or combinations thereof. Suitably, the liquid may be suitable for those following a vegetarian and/or vegan diet, more suitably for those following a vegan diet. Suitably, when the composition is added to a liquid, the composition may be substantially dissolved and/or dispersed in said liquid. Suitably, when the composition is added to a liquid, the composition and/or liquid may comprise further ingredients such as, for example, flavourings and/or additives. Suitably, when present, the flavourings and/or additives may be suitable for those following a vegetarian and/or vegan diet, more suitably for those following a vegan diet.
[67] In certain embodiments, the composition may be added to a foodstuff. Suitable foodstuffs will be well known to a person skilled in the art. For example, the composition may be added to a cereal, chocolate, protein and/or nut bar. Suitably, the foodstuff may be suitable for those following a vegetarian and/or vegan diet, more suitably for those following a vegan diet. Suitably, when the composition is added to a foodstuff, the composition and/or foodstuff may comprise further ingredients such as, for example, flavourings and/or additives. Suitably, when present, the flavourings and/or additives may be suitable for those following a vegetarian and/or vegan diet, more suitably for those following a vegan diet.
[68] In certain embodiments, the composition may be added to a cosmetic composition, such as a cream. Suitable cosmetic compositions and/or creams will be well known to a person skilled in the art. Suitably, when the composition is added to a cosmetic composition, the composition may be substantially dissolved and/or dispersed in the cosmetic composition. Suitably, when the composition is added to a cosmetic composition, the composition and/or cosmetic composition may comprise further ingredients such as, for example, perfumes, emulsifiers and/or additives. Suitably, when present, the perfumes, emulsifiers and/or additives may be suitable for those following a vegetarian and/or vegan diet, more suitably for those following a vegan diet.
[69] In certain embodiments, the composition may be added to a wound dressing. Suitable methods of adding the composition to a wound dressing will be known to a person skilled in the art. Suitably, when the composition is added to a wound dressing, the composition and/or wound dressing may comprise further ingredients such as, for example, medicaments, antiviral agents and/or antibacterial agents.
[70] According to a further aspect of the present invention there is provided a capsule and/or tablet, the capsule and/or tablet comprising a composition according to the first aspect of the present invention.
[71] According to a further aspect of the present invention there is provided the use of a composition comprising a mixture of isolated amino acids to improve the appearance of the skin of a human subject, the mixture of isolated amino acids comprising: a) 15 to 35 wt% glycine, based on the total solid weight of a) to g); b) 5 to 25 wt% proline, based on the total solid weight of a) to g); c) 5 to 25 wt% glutamine, based on the total solid weight of a) to g); d) 5 to 25 wt% hydroxyproline, based on the total solid weight of a) to g); e) 1 to 20 wt% arginine, based on the total solid weight of a) to g); 0 1 to 20 wt% alanine, based on the total solid weight of a) to g); and g) 1 to 15 wt% D-aspartic acid, based on the total solid weight of a) to g); wherein the amount of a), b), c), d), e), f) and g) gives a total of 100 wt% based on the total solid weight of a) to g).
[72] By "improve the appearance of the skin", and like terms as used herein, is meant that the skin of a human subject shows reduced wrinkles and/or reduced dryness when compared to the same human subject before using the composition of the present invention. For example, the reduction in wrinkles and/or reduction in skin dryness may be observed visually.
[73] As used herein, unless otherwise expressly specified, all numbers such as those expressing values, ranges, amounts or percentages may be read as if prefaced by the word "about", even if the term does not expressly appear.
[74] All of the features contained herein may be combined with any of the above aspects and in any combination.
[75] For a better understanding of the invention, and to show how embodiments of the same may be carried into effect, reference will now be made, by way of example, to the following examples.
EXAMPLES
[76] Example 1
[77] A powder composition comprising 100 wt% of a mixture of isolated amino acids as outlined in Table 1 was prepared. Each of the amino acids was a commercially available amino acid sourced from beans. Each amino acid is therefore suitable for those following a vegan diet.
[78] Table 1 -Composition of Example 1 Component Amount / wt% a) Glycine 29.30 b) Proline 15.70 c) Glutamine 13.90 d) Hydroxyproline 12.48 e) Arginine 12.42 U Alanine 9.65 9) D-aspartic acid 6.55 Total 100 [79] The composition is suitable for those following a vegan diet and can be used in products instead of, or as a replacement for, marine collagen.
[80] Attention is directed to all papers and documents which are filed concurrently with or previous to this specification in connection with this application and which are open to public inspection with this specification, and the contents of all such papers and documents are incorporated herein by reference.
[81] All of the features disclosed in this specification (including any accompanying claims, abstract and drawings), and/or all of the steps of any method or process so disclosed, may be combined in any combination, except combinations where at least some of such features and/or steps are mutually exclusive.
[82] Each feature disclosed in this specification (including any accompanying claims, abstract and drawings) may be replaced by alternative features serving the same, equivalent or similar purpose, unless expressly stated otherwise. Thus, unless expressly stated otherwise, each feature disclosed is one example only of a generic series of equivalent or similar features.
[83] The invention is not restricted to the details of the foregoing embodiment(s). The invention extends to any novel one, or any novel combination, of the features disclosed in this specification (including any accompanying claims, abstract and drawings), or to any novel one, or any novel combination, of the steps of any method or process so disclosed.
Claims (15)
- CLAIMSA composition comprising a mixture of isolated amino acids, the mixture of isolated amino acids comprising: a) 15 to 35 wt% glycine, based on the total solid weight of a) to g); b) 5 to 25 wt% proline, based on the total solid weight of a) to g); c) 5 to 25 wt% glutamine, based on the total solid weight of a) to g); d) 5 to 25 wt% hydroxyproline, based on the total solid weight of a) to g); e) 1 to 20 wt% arginine, based on the total solid weight of a) to g); f) 1 to 20 wt% alanine, based on the total solid weight of a) to g); and g) 1 to 15 wt% D-aspartic acid, based on the total solid weight of a) to g); wherein the amount of a), b), c), d), e), f) and g) gives a total of 100 wt% based on the total solid weight of a) to g).
- 2. A composition according to claim 1, wherein components a) to g) are each from a plant-based source.
- 3. A composition according to claims 1 or 2, wherein the mixture of isolated amino acids comprises from 26 to 27 wt% glycine based on the total solid weight of components a) to 9).
- 4 A composition according to any preceding claim, wherein the mixture of isolated amino acids comprises from 16 to 17 wt% proline based on the total solid weight of components a) to g).
- A composition according to any preceding claim, wherein the mixture of isolated amino acids comprises from 14 to 15 wt% glutamine based on the total solid weight of components a) to g).
- 6. A composition according to any preceding claim, wherein the mixture of isolated amino acids comprises from 13 to 14 wt% hydroxyproline based on the total solid weight of components a) to g)
- 7 A composition according to any preceding claim, wherein the mixture of isolated amino acids comprises from 11 to 12 wt% arginine based on the total solid weight of components a) to g)
- 8 A composition according to any preceding claim, wherein the mixture of isolated amino acids comprises from 10 to 11 wt% alanine based on the total solid weight of components a) to g).
- 9 A composition according to any preceding claim, wherein the mixture of isolated amino acids comprises from 6 to 7 wt% D-aspartic acid based on the total solid weight of components a) to g).
- 10. A composition according to any preceding claim, wherein the composition is in the form of a powder.
- 11. A composition according to any preceding claim, wherein the composition is added to a liquid and/or foodstuff.
- 12. A capsule and/or tablet, the capsule and/or tablet comprising a composition according to claim 1.
- 13. A capsule and/or tablet according to claim 12, wherein the tablet may be in the form of a compressed powder.
- 14. A capsule and/or tablet according to claim 12, wherein the capsule is formed from hydroxypropyl methylcellulose (HPMC).
- 15. Use of a composition comprising a mixture of isolated amino acids to improve the appearance of the skin of a human subject, the mixture of isolated amino acids comprising: a) 15 to 35 wt% glycine, based on the total solid weight of a) to g); b) 5 to 25 wt% proline, based on the total solid weight of a) to g); c) 5 to 25 wt% glutamine, based on the total solid weight of a) to g); d) 5 to 25 wt% hydroxyproline, based on the total solid weight of a) to g); e) 1 to 20 wt% arginine, based on the total solid weight of a) to g); 0 1 to 20 wt% alanine, based on the total solid weight of a) to g); and g) 1 to 15 wt% D-aspartic acid, based on the total solid weight of a) to g); wherein the amount of a), b), c), d), e), f) and g) gives a total of 100 wt% based on the total solid weight of a) to g).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1818629.6A GB2579036A (en) | 2018-11-15 | 2018-11-15 | Compositions comprising amino acids |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1818629.6A GB2579036A (en) | 2018-11-15 | 2018-11-15 | Compositions comprising amino acids |
Publications (2)
Publication Number | Publication Date |
---|---|
GB201818629D0 GB201818629D0 (en) | 2019-01-02 |
GB2579036A true GB2579036A (en) | 2020-06-10 |
Family
ID=64740008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1818629.6A Withdrawn GB2579036A (en) | 2018-11-15 | 2018-11-15 | Compositions comprising amino acids |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2579036A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4371419A1 (en) * | 2022-11-15 | 2024-05-22 | Avea Life AG | Non-therapeutic use of a composition for maintaining or prolonging collagen homeostasis in a living organism during aging |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998027202A1 (en) * | 1996-12-17 | 1998-06-25 | Meristem Therapeutics S.A. | Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses |
US6335004B1 (en) * | 2000-05-31 | 2002-01-01 | Ecolab Inc. | Odorless phenolic compositions |
EP1582208A2 (en) * | 2004-04-01 | 2005-10-05 | Ajinomoto Co., Inc. | An amino acid compositions for promoting collagen synthesis |
-
2018
- 2018-11-15 GB GB1818629.6A patent/GB2579036A/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998027202A1 (en) * | 1996-12-17 | 1998-06-25 | Meristem Therapeutics S.A. | Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses |
US6335004B1 (en) * | 2000-05-31 | 2002-01-01 | Ecolab Inc. | Odorless phenolic compositions |
EP1582208A2 (en) * | 2004-04-01 | 2005-10-05 | Ajinomoto Co., Inc. | An amino acid compositions for promoting collagen synthesis |
Non-Patent Citations (5)
Title |
---|
HITOSHI MURAKAMI ET AL: "Importance of amino acid composition to improve skin collagen protein synthesis rates in UV-irradiated mice", AMINO ACIDS ; THE FORUM FOR AMINO ACID AND PROTEIN RESEARCH, SPRINGER-VERLAG, VI, vol. 42, no. 6, 23 August 2011 (2011-08-23), pages 2481 - 2489, XP035055882, ISSN: 1438-2199, DOI: 10.1007/S00726-011-1059-Z * |
LI PENG ET AL: "Roles of dietary glycine, proline, and hydroxyproline in collagen synthesis and animal growth", AMINO ACIDS, SPRINGER VERLAG, AU, vol. 50, no. 1, 20 September 2017 (2017-09-20), pages 29 - 38, XP036400224, ISSN: 0939-4451, [retrieved on 20170920], DOI: 10.1007/S00726-017-2490-6 * |
MURAKAMI HITOSHI ET AL: "Combination of BCAAs and glutamine enhances dermal collagen protein synthesis in protein-malnourished rats", AMINO ACIDS (VIENNA), vol. 44, no. 3, March 2013 (2013-03-01), pages 969 - 976, XP002789583 * |
PIEPER J S ET AL: "Crosslinked type II collagen matrices: preparation, characterization, and potential for cartilage engineering", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 23, no. 15, 1 August 2002 (2002-08-01), pages 3183 - 3192, XP004354888, ISSN: 0142-9612, DOI: 10.1016/S0142-9612(02)00067-4 * |
WILLIAMS JEREMY Z ET AL: "Effect of a specialized amino acid mixture on human collagen deposition.", ANNALS OF SURGERY SEP 2002, vol. 236, no. 3, September 2002 (2002-09-01), pages 369, XP002789584, ISSN: 0003-4932 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4371419A1 (en) * | 2022-11-15 | 2024-05-22 | Avea Life AG | Non-therapeutic use of a composition for maintaining or prolonging collagen homeostasis in a living organism during aging |
EP4374708A1 (en) * | 2022-11-15 | 2024-05-29 | Avea Life AG | Nutritional supplement preparation |
Also Published As
Publication number | Publication date |
---|---|
GB201818629D0 (en) | 2019-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5894341B2 (en) | Composition comprising collagen peptide, elastin peptide and proteoglycan | |
KR102372691B1 (en) | Method for masking bitterness of composition containing collagen peptide | |
RU2221456C1 (en) | Biologically active substance, biologically active supplement to food, pharmaceutical preparation, biologically active supplement for feeding animal, veterinary preparation, fertilizer, activator of microbiological process, oral nutrition, perfume-cosmetic agent, hygienic agent, dairy foodstuff, confectionery, baked goods, butter-fat foodstuff, sauce, alcohol drink, nonalcoholic beverage, piscine foodstuff, meat foodstuff, macaroni article, chewing gum, beer | |
CN109645079A (en) | A kind of generation meal ship biscuit and its preparation and application with antiobesity action | |
JP5888574B1 (en) | Blood flow improver | |
JP2024009190A (en) | Bone fortifier dietary supplements | |
JP2007049952A (en) | Noodle string dough and method for producing the same | |
NL2004960C2 (en) | Meat composition containing textured vegetable protein, process for the preparation thereof, and meat substitute. | |
DE60038350T2 (en) | Angiotensin-converting enzyme inhibitors | |
GB2579036A (en) | Compositions comprising amino acids | |
JP4045401B2 (en) | Degradation composition of royal jelly by proteolytic enzyme and food composition containing the same | |
AU2015297348B2 (en) | Adiponectin secretion regulator | |
KR100462331B1 (en) | Korean fermented hot pepper-soybean paste and Korean fermented soybean paste with weight loss effect | |
RU2601571C1 (en) | Sausages | |
JP5712393B2 (en) | Collagen absorption promoter and use thereof | |
JP2008044890A (en) | Composition for breast enlargement and food and beverage for breast enlargement | |
KR100822815B1 (en) | Noodle including squid and manufacturing method thereof | |
JP2008174459A (en) | Anti-aging agent, external preparation for skin and food and drink for beauty | |
RU2795598C1 (en) | Food product based on vegetable raw materials in the form of nuggetts | |
RU2404690C1 (en) | Crab paste | |
RU2795863C1 (en) | Plant food substitute meat | |
AU2019100551A4 (en) | Superfood Spreads. A healthy five ingredient combination of raw fruits, nuts, seeds, vegetables, leaves and superfood powders to create a new age spread for toast and any other application. | |
Puri et al. | Evaluation of the nutritional value of snacks prepared by fortification of gram flour with chia seeds | |
JP2007300862A (en) | Collagen producing food | |
JPS58155058A (en) | Separation-type liquid seasoning |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |